TearLab Corp - Strategic SWOT Analysis Review

TearLab Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description - A detailed description of the company's operations and business divisions.
• Corporate strategy - The publisher's summarization of the company's business strategy.
• SWOT analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands of the company.
• Key competitors - A list of key competitors to the company.
• Key employees - A list of the key executives of the company.
• Executive biographies - A brief summary of the executives' employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

TearLab Corp (TearLab) is an in-vitro diagnostic company which focuses on ophthalmic devices. It commercializes a proprietary in vitro diagnostic tear testing platform. The company's flagship product TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. Its osmolarity system is a CE marked and the US FDA cleared device. TearLab conducts research and development activities through its wholly-owned subsidiary, TearLab Research Inc. It sells products directly in the US. The company also sells products through distributors in Europe, Canada, Australia, Central and South America, and Asia. TearLab is headquartered in Escondido, California, the US.

TearLab Corp Key Recent Developments

Dec 09, 2021: TearLab Corporation Announces Adam Szaronos as President and Chief Executive Officer, and Jim Mazzo as Executive Chairman of the Board
Sep 16, 2021: MellingMedical and TearLab agreement aims to enhance early detection of dry eye disease in American veterans

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors' business structure and strategies with the publisher's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.